Paper Details

  1. Home
  2. Paper Details

The use of monoamine pharmacological agents in the treatment of sexual dysfunction: evidence in the literature.

Author: BrownCandace S, MollJennifer L

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Monoaminergic agents, such as bupropion, buspirone, and ropinirole, may be effective in treating sexual dysfunction, especially those caused by serotonergic reuptake inhibitors.
Paper Details　
Original Abstract of the Article :
INTRODUCTION: The monoamine neurotransmitters serotonin, dopamine, and norepinephrine play an important role in many medical and psychological conditions, including sexual responsiveness and behavior. Pharmacological agents that modulate monoamines may help alleviate sexual dysfunction. AIMS: To pr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/21272265

データ提供：米国国立医学図書館（NLM）

The Intricate Connection Between Monoamines and Sexual Function

In the realm of human health, sexual function is a complex and multifaceted aspect of well-being. This study dives deep into the intricate connection between monoamine neurotransmitters, crucial chemical messengers in the brain, and sexual dysfunction. The authors review the evidence surrounding the use of pharmacological agents that modulate monoamines, offering insights into their potential role in treating sexual dysfunction.

Monoaminergic Agents: A Potential Solution for Sexual Dysfunction?

The study explores the potential of monoaminergic agents in treating sexual dysfunction, focusing on their use in managing sexual side effects associated with serotonergic reuptake inhibitors (SSRIs). The authors present evidence supporting the efficacy of agents like bupropion, buspirone, and ropinirole in improving sexual dysfunction. They also discuss the use of other agents like nefazodone and apomorphine, highlighting their limitations due to potential side effects and safety concerns.

Navigating the Complexities of Sexual Health

This research, like a guidepost in the vast desert of sexual health, sheds light on the potential role of monoaminergic agents in managing sexual dysfunction. The findings suggest that these agents may offer a therapeutic avenue for addressing sexual problems, particularly those associated with SSRI use. It's essential to consult with healthcare professionals for a comprehensive evaluation and personalized treatment plan.

Dr.Camel's Conclusion

This study, like a caravan navigating the intricate pathways of the brain, reveals the complex relationship between monoamines and sexual function. The findings offer insights into the potential use of monoaminergic agents for addressing sexual dysfunction, highlighting the importance of further research and careful consideration of individual needs in managing this sensitive aspect of human health.

Date :
  1. Date Completed 2011-09-06
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

21272265

DOI: Digital Object Identifier

S1743-6095(15)33483-4

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.